ABCB1 and endometrial cancer: A study by Alhag-Soluman and colleagues showed that a new ciprofloxacin derivative inhibited MDR1, increasing paclitaxel accumulation in drug-resistant endometrial cancer cells and boosting its efficacy (Figure 3G) [24].